Full history for every metric is available with a Kvantra account

Stock profile
Bangkok Dusit Medical Services Public Company Limited logo

Bangkok Dusit Medical Services Public Company Limited (BDMS.BK)

Country: ThailandSector: HealthcareIndustry: Medical - Care FacilitiesExchange: SET
P/E TTM
20.2
History
P/E NTM
18.2
Market cap
308.3B
Currency THB
KvantraRankAbout75
IValue75
IIQuality83
IIIMomentum66
Current price
19.40 THB-0.51%
Close 22 Oct 2026
Interval
Benchmarks

Key financial summary

Financials in THB
202020212022202320242025TTM2026E
Total revenueTHB bn687492101108112112114
Operating profitTHB bn18.517.6
Net profitTHB bn7.27.912.614.416.015.815.316.2
EPS reportedTHB1.000.96
Operating cashflow per shareTHB1.481.36
Capex per shareTHB0.660.56
FCF per shareTHB0.820.81
Free cash flowTHB bn13.012.8
Net debtTHB bn2.315.2
Book value equityTHB bn106103
Book value per shareTHB6.666.50
Number of sharesm15,89215,892
DPS (TTM paid)THB1.001.00

Financial summary

Financials in THB
202020212022202320242025TTM2026E
Value
P/E TTMx19.3020.21
P/B LTMx2.902.99
P/S LTMx2.752.76
P/FCF LTMx23.5324.05
EV/EBITDA LTMx12.5612.81
EV/Sales LTMx2.852.89
Earnings Yield LTM%5.18%4.95%
FCF Yield%4.25%4.16%
Quality
ROE%14.97%14.60%
ROIC%10.67%10.21%
Operating margin%16.56%15.74%
Gross margin%34.91%35.40%
FCF/Sales%11.69%11.46%
Growth and momentum
EPS Growth YoY%-0.99%-6.80%
Sales Growth YoY%+3.37%+1.30%
Net Income Growth YoY%-0.87%-6.68%
FCF Growth%+15.57%+18.74%
Operating Profit Growth%-10.00%-16.41%
Dividend and capital structure
Dividend Yield%3.89%5.15%
Dividend Growth%+33.33%+33.33%
Payout Ratio%74.98%104.16%
FCF/Debtx0.750.67
Net Debt/EBITDAx0.440.60
EBIT/Net interestx51.7855.35
Net debt/market cap%0.74%4.92%
Net debt/Equityx0.020.15
Gross debt/equityx0.170.18

ETFs that hold Bangkok Dusit Medical Services Public

FundTickerPosition#Weight
iShares MSCI Thailand ETFTHD73.85%
Xtrackers MSCI Thailand UCITS ETF 1CXCS4.DE75.37%

Funds with Bangkok Dusit Medical Services Public among their ten largest holdings, largest fund first.

Ratings

Strong Buy
Buy
Hold
Sell
Strong Sell
Number of covering analysts

Based on consensus from external analysts. Not Kvantra's opinion.

Company overview

Bangkok Dusit Medical Services Public Company Limited (BDMS) functions as a prominent healthcare conglomerate, with its subsidiaries primarily engaged in operating and owning hospitals. The company oversees a portfolio of six major hospital networks, specifically the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. Beyond providing extensive medical treatment, BDMS also offers holistic clinical wellness programs. Its diversified business interests extend to hospitality, managing hotels and restaurants, as well as retailing health and beauty products. The company provides a broad spectrum of specialized services, including laboratory testing, advanced genome sequencing, skin and aesthetic telemedicine, and air medical transportation. Additionally, BDMS delivers business-centric services such as accounting, investment management, information technology, training, various insurance solutions (including health insurance and brokerage), and property and asset management. Its operations further encompass pharmaceutical manufacturing and distribution, e-commerce, and real estate ventures. BDMS maintains a significant presence with 47 hospitals operating across Thailand and Cambodia. The company was established in 1969 and is headquartered in Bangkok, Thailand.

Websitebdms.co.th
Trades inTHB

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Bangkok Dusit Medical Services Public Company Limited (BDMS.BK)

BDMS.BK · SET · Healthcare
19.40 THB-0.51%
Sign up to track this stock
Benchmarks
KvantraRank75
Market cap308.3B
P/E NTM18.2
P/E TTM20.2
KvantraRank?75 / 100
Value
75
Quality
83
Momentum
66
Financialsin THB
20242025TTM2026E
ETFs that hold Bangkok Dusit Medical Services Public
FundTickerPosition#Weight
iShares MSCI Thailand ETFTHD73.85%
Xtrackers MSCI Thailand UCITS ETF 1CXCS4.DE75.37%

Funds with Bangkok Dusit Medical Services Public among their ten largest holdings, largest fund first.

Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Based on consensus from external analysts. Not Kvantra's opinion.

About

Bangkok Dusit Medical Services Public Company Limited (BDMS) functions as a prominent healthcare conglomerate, with its subsidiaries primarily engaged in operating and owning hospitals. The company oversees a portfolio of six major hospital networks, specifically the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. Beyond providing extensive medical treatment, BDMS also offers holistic clinical wellness programs. Its diversified business interests extend to hospitality, managing hotels and restaurants, as well as retailing health and beauty products. The company provides a broad spectrum of specialized services, including laboratory testing, advanced genome sequencing, skin and aesthetic telemedicine, and air medical transportation. Additionally, BDMS delivers business-centric services such as accounting, investment management, information technology, training, various insurance solutions (including health insurance and brokerage), and property and asset management. Its operations further encompass pharmaceutical manufacturing and distribution, e-commerce, and real estate ventures. BDMS maintains a significant presence with 47 hospitals operating across Thailand and Cambodia. The company was established in 1969 and is headquartered in Bangkok, Thailand.

Websitebdms.co.th
IndustryMedical - Care Facilities
CountryThailand
Trades inTHB

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free